Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 8
2004 14
2005 13
2006 18
2007 16
2008 12
2009 20
2010 27
2011 23
2012 23
2013 26
2014 28
2015 31
2016 28
2017 21
2018 21
2019 26
2020 11
2021 18
2022 23
2023 28
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Results by year

Filters applied: . Clear all
Page 1
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).
Frodlund M, Nived P, Chatzidionysiou K, Södergren A, Klingberg E, Hansson M, Ohlsson S, Pin E, Bengtsson A, Klareskog L, Kapetanovic M. Frodlund M, et al. Among authors: klareskog l. Microbiol Spectr. 2024 Apr 2;12(4):e0298123. doi: 10.1128/spectrum.02981-23. Epub 2024 Mar 5. Microbiol Spectr. 2024. PMID: 38441463 Free article.
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages.
Marcotte H, Cao Y, Zuo F, Simonelli L, Sammartino JC, Pedotti M, Sun R, Cassaniti I, Hagbom M, Piralla A, Yang J, Du L, Percivalle E, Bertoglio F, Schubert M, Abolhassani H, Sherina N, Guerra C, Borte S, Rezaei N, Kumagai-Braesch M, Xue Y, Su C, Yan Q, He P, Grönwall C, Klareskog L, Calzolai L, Cavalli A, Wang Q, Robbiani DF, Hust M, Shi Z, Feng L, Svensson L, Chen L, Bao L, Baldanti F, Xiao J, Qin C, Hammarström L, Yang X, Varani L, Xie XS, Pan-Hammarström Q. Marcotte H, et al. Among authors: klareskog l. Proc Natl Acad Sci U S A. 2024 Jan 16;121(3):e2315354120. doi: 10.1073/pnas.2315354120. Epub 2024 Jan 9. Proc Natl Acad Sci U S A. 2024. PMID: 38194459 Free PMC article.
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation.
Pertsinidou E, Saevarsdottir S, Manivel VA, Klareskog L, Alfredsson L, Mathsson-Alm L, Hansson M, Cornillet M, Serre G, Holmdahl R, Skriner K, Jakobsson PJ, Westerlind H, Askling J, Rönnelid J. Pertsinidou E, et al. Among authors: klareskog l. Ann Rheum Dis. 2024 Feb 15;83(3):277-287. doi: 10.1136/ard-2023-224728. Ann Rheum Dis. 2024. PMID: 38049984 Free PMC article.
Reply.
Alfredsson L, Klareskog L, Hedström AK. Alfredsson L, et al. Among authors: klareskog l. Arthritis Rheumatol. 2024 Apr;76(4):660-661. doi: 10.1002/art.42762. Epub 2023 Dec 18. Arthritis Rheumatol. 2024. PMID: 37986134 No abstract available.
Autoreactive B cells against malondialdehyde-induced protein cross-links are present in the joint, lung, and bone marrow of rheumatoid arthritis patients.
Sahlström P, Joshua V, Valkovskaia V, Biese C, Stålesen R, Israelsson L, Végvári Á, Scheel-Toellner D, Klareskog L, Hansson M, Hensvold A, Malmström V, Grönwall C. Sahlström P, et al. Among authors: klareskog l. J Biol Chem. 2023 Nov;299(11):105320. doi: 10.1016/j.jbc.2023.105320. Epub 2023 Oct 4. J Biol Chem. 2023. PMID: 37802315 Free PMC article.
Reply.
Alfredsson L, Klareskog L, Hedström AK. Alfredsson L, et al. Among authors: klareskog l. Arthritis Rheumatol. 2024 Mar;76(3):487-488. doi: 10.1002/art.42719. Epub 2023 Oct 26. Arthritis Rheumatol. 2024. PMID: 37732938 No abstract available.
Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.
Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman ÅK, Kalnapenkis A, Enroth S, Cozzetto D, Digby-Bell J, Marten J, Folkersen L, Herder C, Jonsson L, Bergen SE, Gieger C, Needham EJ, Surendran P; Estonian Biobank Research Team; Paul DS, Polasek O, Thorand B, Grallert H, Roden M, Võsa U, Esko T, Hayward C, Johansson Å, Gyllensten U, Powell N, Hansson O, Mattsson-Carlgren N, Joshi PK, Danesh J, Padyukov L, Klareskog L, Landén M, Wilson JF, Siegbahn A, Wallentin L, Mälarstig A, Butterworth AS, Peters JE. Zhao JH, et al. Among authors: klareskog l. Nat Immunol. 2023 Nov;24(11):1960. doi: 10.1038/s41590-023-01635-6. Nat Immunol. 2023. PMID: 37679551 Free PMC article. No abstract available.
Prevention vs treatment of rheumatoid arthritis.
Klareskog L, Alfredsson L. Klareskog L, et al. Immunother Adv. 2023 Aug 29;3(1):ltad016. doi: 10.1093/immadv/ltad016. eCollection 2023. Immunother Adv. 2023. PMID: 37662832 Free PMC article. Review.
392 results